Diagnosis Code C86.5. ICD-10: C86.5. Short Description: Angioimmunoblastic T-cell lymphoma. Long Description: Angioimmunoblastic T-cell lymphoma. This is the 2018 version of the ICD-10-CM diagnosis code C86.5.
Valid for Submission. C86.5 is a billable code used to specify a medical diagnosis of angioimmunoblastic t-cell lymphoma. The code is valid for the year 2020 for the submission of HIPAA-covered transactions.
Adult T-cell lymphoma/leukemia (HTLV-1-associated) 2016 2017 2018 2019 Non-Billable/Non-Specific Code. C91.5 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. The 2019 edition of ICD-10-CM C91.5 became effective on October 1, 2018.
Angioimmunoblastic T-cell lymphoma (AITL) is a neoplasm of mature T follicular helper (TFH) cell s characterized by systemic disease and a polymorphous infiltrate involving lymph node s, with a prominent proliferation of high endothelial venules (HEVs) and follicular dendritic cell s (FDCs).
AITL is a type of peripheral T-cell lymphoma. It is a high grade (aggressive) lymphoma that affects blood cells called T cells. High grade lymphomas tend to grow more quickly than low grade lymphomas. AITL usually affects older people, typically around the age of 70.
Angioimmunoblastic T-cell lymphoma (AITL) is a rare, often but not always, aggressive (fast-growing) form of peripheral T-cell lymphoma (PTCL). While AITL only accounts for one to two percent of all NHL cases in the United States, it is one of the more common subtypes of T-cell lymphomas.
Abstract. Angioimmunoblastic lymphadenopathy with dysproteinemia (AILD) is a rare lymphoproliferative disorder characterized by diffuse lymphadenopathy, fever, hepatosplenomegaly, hemolytic anemia, and polyclonal hypergammaglobulinemia.
Infectious diseases associated with angioimmunoblastic T-cell lymphoma include Epstein-Barr virus (EBV, the cause of infectious mononucleosis), human herpesvirus 6 (HHV-6) (the cause of roseola), HHV-8 (the cause of Kaposi sarcoma), human immunodeficiency virus (HIV), bacterial infections and fungal infections [4].
T-lymphoblastic lymphoma (T-LBL) is a rare form of aggressive non-Hodgkin's lymphoma. The standard approach for management of T-LBL involves intensive multiagent chemotherapy regimens for induction and consolidation phases with central nervous system prophylaxis and a maintenance phase lasting 12-18 months.
Types of T-cell lymphomaT-lymphoblastic lymphoma/leukemia.Peripheral T-cell lymphomas, which is one of the following:Cutaneous T-cell lymphomas.Adult T-cell leukemia/lymphoma.Angioimmunoblastic T-cell lymphoma.Extranodal natural killer/T-cell lymphoma, nasal type.More items...•
Peripheral T-cell lymphoma (PTCL) is defined as a diverse group of aggressive lymphomas that develop from mature-stage white blood cells called T-cells and natural killer (NK) cells. PTCL is classified as a subtype of non-Hodgkin's lymphoma (NHL).
What is ALCL? Anaplastic large cell lymphoma (ALCL) is a type of T-cell lymphoma – a non-Hodgkin lymphoma that develops from white blood cells called T cells. Under a microscope, the cancerous cells in ALCL look large, undeveloped and very abnormal ('anaplastic').
Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen.
In general, relapsed lymphoma remains potentially curable; however, required approaches are significantly more aggressive and therefore riskier than the initial treatment. AITL cure remains elusive in the majority of patients.
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code C86.5:
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code (s). The following references for the code C86.5 are found in the index:
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code C86.5 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
Lymphoma is a cancer of a part of the immune system called the lymph system. There are many types of lymphoma. One type is Hodgkin disease. The rest are called non-Hodgkin lymphomas.
Angioimmunoblastic T-cell lymphoma (AITL, sometimes misspelled AILT) (formerly known as "Angioimmunoblastic lymphadenopathy with dysproteinemia":747) is a mature T-cell lymphoma of blood or lymph vessel immunoblasts characterized by a polymorphous lymph node infiltrate showing a marked increase in follicular dendritic cells (FDCs) and high endothelial venules (HEVs) and systemic involvement.
Inclusion Terms are a list of concepts for which a specific code is used. The list of Inclusion Terms is useful for determining the correct code in some cases, but the list is not necessarily exhaustive.
DRG Group #820-822 - Lymphoma and leukemia with major operating room procedure with MCC.
The ICD-10-CM Alphabetical Index links the below-listed medical terms to the ICD code C86.5. Click on any term below to browse the alphabetical index.
This is the official approximate match mapping between ICD9 and ICD10, as provided by the General Equivalency mapping crosswalk. This means that while there is no exact mapping between this ICD10 code C86.5 and a single ICD9 code, 200.80 is an approximate match for comparison and conversion purposes.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
It is endemic in japan, the caribbean basin, southeastern United States, hawaii, and parts of central and south america and sub-saharan africa. An aggressive (fast-growing) type of t-cell non-hodgkin lymphoma caused by the human t-cell leukemia virus type 1 (htlv-1).
Lymphoid leukemia. Clinical Information. A peripheral (mature) t-cell neoplasm caused by the human t-cell leukemia virus type 1 (htlv-1). Adult t-cell leukemia/lymphoma is endemic in several regions of the world, in particular japan, the caribbean, and parts of central africa. (who, 2001)
The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes. Primary malignant neoplasms overlapping site boundaries.